Journal article 136 views 7 downloads
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials / Subodh Verma, Darren K. McGuire, Steve Bain, Deepak L. Bhatt, Lawrence A. Leiter, C. David Mazer, Tea Monk Fries, Richard E. Pratley, Søren Rasmussen, Hrvoje Vrazic, Bernard Zinman, John B. Buse
Diabetes, Obesity and Metabolism, Volume: 22, Issue: 12
Swansea University Author: Steve Bain
-
PDF | Accepted Manuscript
Download (648.14KB)
DOI (Published version): 10.1111/dom.14160
Abstract
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| ISSN: | 1462-8902 1463-1326 |
| Published: |
Wiley
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa54840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Issue: |
12 |
|---|